Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 8163588)

1.

Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.

Bullock R, Graham DI, Swanson S, McCulloch J.

J Cereb Blood Flow Metab. 1994 May;14(3):466-71.

2.

YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.

Takahashi M, Ni JW, Kawasaki-Yatsugi S, Toya T, Yatsugi SI, Shimizu-Sasamata M, Koshiya K, Shishikura JI, Sakamoto S, Yamaguchi T.

J Pharmacol Exp Ther. 1998 Feb;284(2):467-73.

3.

Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977.

Mackay KB, Kusumoto K, Graham DI, McCulloch J.

Brain Res. 1993 Aug 6;618(2):213-9.

PMID:
8397047
4.

Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats.

Yatsugi S, Takahashi M, Kawasaki-Yatsugi S, Koshiya K, Sakamoto S, Uematsu D, Shimizu-Sasamata M.

J Cereb Blood Flow Metab. 1996 Sep;16(5):959-66.

5.

Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene.

Bullock R, Graham DI, Chen MH, Lowe D, McCulloch J.

J Cereb Blood Flow Metab. 1990 Sep;10(5):668-74.

6.

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

Ozyurt E, Graham DI, Woodruff GN, McCulloch J.

J Cereb Blood Flow Metab. 1988 Feb;8(1):138-43.

7.

Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia.

Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J.

J Cereb Blood Flow Metab. 1988 Oct;8(5):757-62.

8.

Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502.

McCracken E, Fowler JH, Dewar D, Morrison S, McCulloch J.

J Cereb Blood Flow Metab. 2002 Sep;22(9):1090-7.

9.

A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.

Kawasaki-Yatsugi S, Yatsugi S, Takahashi M, Toya T, Ichiki C, Shimizu-Sasamata M, Yamaguchi T, Minematsu K.

Brain Res. 1998 May 18;793(1-2):39-46.

PMID:
9630503
10.

YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.

Takahashi M, Kohara A, Shishikura J, Kawasaki-Yatsugi S, Ni JW, Yatsugi S, Sakamoto S, Okada M, Shimizu-Sasamata M, Yamaguchi T.

CNS Drug Rev. 2002 Winter;8(4):337-52. Review.

PMID:
12481190
11.
12.

Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats.

Akiho H, Iwai A, Tsukamoto S, Koshiya K, Yamaguchi T.

Neuropharmacology. 1998;37(2):159-68.

PMID:
9680240
13.

Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia.

Chen M, Bullock R, Graham DI, Frey P, Lowe D, McCulloch J.

Ann Neurol. 1991 Jul;30(1):62-70.

PMID:
1834008
14.

AMPA antagonist LY293558 does not affect the severity of hypoxic-ischemic injury in newborn pigs.

LeBlanc MH, Li XQ, Huang M, Patel DM, Smith EE.

Stroke. 1995 Oct;26(10):1908-14; discussion 1914-5.

15.

Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.

Matucz E, Móricz K, Gigler G, Simó A, Barkóczy J, Lévay G, Hársing LG Jr, Szénási G.

Brain Res. 2004 Sep 3;1019(1-2):210-6.

PMID:
15306255
16.

Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats.

Miyabe M, Kirsch JR, Nishikawa T, Koehler RC, Traystman RJ.

Crit Care Med. 1997 Jun;25(6):1037-43.

PMID:
9201058
17.

AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.

Yao H, Ibayashi S, Nakane H, Cai H, Uchimura H, Fujishima M.

Brain Res. 1997 Apr 4;753(1):80-5.

PMID:
9125434
18.

Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat.

Bannan PE, Graham DI, Lees KR, McCulloch J.

Brain Res. 1994 Nov 21;664(1-2):271-5.

PMID:
7895041
19.

YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.

Kawasaki-Yatsugi S, Ichiki C, Yatsugi S, Shimizu-Sasamata M, Yamaguchi T.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Nov;358(5):586-91.

PMID:
9840429
20.

Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.

Kawasaki-Yatsugi S, Shimizu-Sasamata M, Yatsugi S, Yamaguchi T.

J Pharm Pharmacol. 1998 Aug;50(8):891-8.

PMID:
9751454
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk